Key Stats
Founded: May 1, 1835 in Dresden, Germany
Headquarters: Stuttgart, Baden-Württemberg, Germany
Acquired by McKesson Corporation: January 2014 for €6.1 billion
Peak Revenue: €22.3 billion (2007)
Employees at Acquisition: Approximately 37,000
Celesio AG operated as a leading European pharmaceutical distribution and healthcare services company before its acquisition by McKesson Corporation. The company provided wholesale distribution, retail pharmacy operations, and logistics services to the pharmaceutical industry.
Celesio AG operated through three main business divisions: Patient and Consumer Solutions, Pharmacy Solutions, and Manufacturer Solutions. The company served pharmacies, hospitals, and healthcare institutions across Europe with pharmaceutical products and healthcare supplies.
At its peak, Celesio AG maintained operations in 16 countries and supplied over 65,000 pharmacies and hospitals through 133 wholesale branches. The company generated annual revenues exceeding €22 billion before becoming part of McKesson’s global healthcare network.
Celesio AG History
Celesio AG traces its roots to 1835 when merchant Franz Ludwig Gehe founded a drugstore and paint supply business in Dresden, Germany. The young entrepreneur established Gehe & Comp. to import and distribute chemicals, drugs, and pharmaceutical products to local apothecaries.
The company grew steadily through the 19th century as pharmaceutical demand increased during Germany’s industrialization period. In 1903, Gehe & Comp. converted to a public limited company, opening itself to capital markets and enabling nationwide expansion.
1835
Franz Ludwig Gehe founded Gehe & Comp. in Dresden as Germany’s first dedicated drug wholesale business, importing chemicals and pharmaceutical products.
1903
Company converted to public limited company (AG) and opened to capital markets. Shares began trading on Dresden stock exchange in January 1904.
1922
First German branch outside Dresden established in Stuttgart. Post-war recovery shifted headquarters operations westward.
1973
Franz Haniel & Cie. acquired majority stake in GEHE AG. Company achieved turnover of DM 285 million and began aggressive expansion.
1993
Acquired OCP S.A. in France, becoming Europe’s largest pharmaceutical wholesaler. Restructured as holding company with separate operating divisions.
1995
Acquired AAH Pharmaceuticals, the UK’s leading pharmaceutical wholesaler. Entry into retail pharmacy business through AAH’s pharmacy network.
1997
Acquired Lloyds Chemists PLC and merged it with Hills Pharmacy network to create 1,300-pharmacy retail chain in the United Kingdom.
2003
Shareholders voted 99.98% to rename GEHE AG to Celesio AG, reflecting the company’s evolution into a European healthcare leader.
2009
Acquired majority stake in Panpharma, Brazil’s largest pharmaceutical wholesaler. Expanded presence in emerging markets beyond Europe.
2014
McKesson Corporation acquired Celesio AG for €6.1 billion (€23 per share). Company later renamed McKesson Europe in 2017.
Celesio AG Co-founders
Franz Ludwig Gehe (1810-1882)
German merchant who founded Gehe & Comp. in Dresden in 1835. Pioneered pharmaceutical wholesale distribution in Germany and established the company’s foundation.
Dr. Rudolph August Luboldt (1831-1894)
Apothecary and chemist who joined the company in 1859. His pharmaceutical expertise expanded the company’s product offerings and manufacturing capabilities.
Celesio AG Competitors
Celesio AG competed in the European pharmaceutical distribution market against regional wholesalers and international healthcare companies. The competitive landscape included both specialized distributors and integrated healthcare providers operating across multiple countries.
| Company | Headquarters | Products/Services |
|---|---|---|
| Phoenix Group | Mannheim, Germany | Pharmaceutical wholesale, retail pharmacy |
| Alliance Healthcare | Chessington, UK | Pharmaceutical distribution, logistics |
| Cardinal Health | Dublin, Ohio, USA | Pharmaceutical distribution, medical supplies |
| AmerisourceBergen (Cencora) | Conshohocken, PA, USA | Pharmaceutical distribution, specialty |
| Walgreens Boots Alliance | Deerfield, Illinois, USA | Retail pharmacy, wholesale distribution |
| CVS Health | Woonsocket, RI, USA | Retail pharmacy, pharmacy benefits |
| Mediq | Utrecht, Netherlands | Medical supplies, pharmaceutical distribution |
| Tamro Corporation | Vantaa, Finland | Pharmaceutical wholesale, Nordic markets |
| Brocacef Holding | Maarssen, Netherlands | Pharmaceutical wholesale, retail pharmacy |
| Sanacorp | Planegg, Germany | Pharmaceutical wholesale, pharmacy services |
Celesio AG Marketcap
Celesio AG traded on the Frankfurt Stock Exchange and was a component of the MDAX index until 2015. The company’s market capitalization fluctuated significantly during the years leading up to its acquisition by McKesson Corporation.
Celesio AG Market Capitalization (in Billions EUR)
*2014 reflects McKesson acquisition valuation
Celesio AG Revenue
Celesio AG maintained relatively stable revenues throughout its final decade as an independent company. The pharmaceutical distribution business generated consistent income streams despite European healthcare market pressures and regulatory changes.
Celesio AG Annual Revenue (in Billions EUR)
Celesio AG Acquisitions
Celesio AG pursued an aggressive acquisition strategy to build its position as Europe’s leading pharmaceutical distributor. The company expanded through strategic purchases of wholesale operations, retail pharmacy chains, and logistics providers across the continent.
The 1993 acquisition of Office Commercial Pharmaceutique (OCP) in France marked a turning point for the company. This deal transformed GEHE AG from a German wholesaler into Europe’s largest pharmaceutical distribution company. OCP brought established operations in France, Belgium, and Portugal, providing immediate pan-European presence.
In 1995, Celesio acquired AAH Pharmaceuticals, the United Kingdom’s leading pharmaceutical wholesaler. AAH supplied medications to pharmacies, hospitals, and healthcare institutions throughout Britain. This purchase gave Celesio access to the UK market and established infrastructure for further expansion.
Two years later, the company acquired Lloyds Chemists PLC and merged it with AAH’s Hills Pharmacy network. The combined operation created a retail pharmacy chain with over 1,300 locations across the UK. LloydsPharmacy became one of Britain’s largest community pharmacy operators, serving millions of customers annually.
Celesio ventured into mail-order pharmacy in 2007 by acquiring 90% of DocMorris, a Dutch online pharmacy. The acquisition aimed to build a German pharmacy chain, though regulatory challenges limited this strategy. Celesio later sold DocMorris to Zur Rose AG in 2012.
The company expanded beyond Europe in 2009 when it acquired majority control of Panpharma, Brazil’s largest pharmaceutical wholesaler. This move represented Celesio’s first significant entry into emerging markets outside its traditional European base. Celesio completed full ownership of Panpharma in 2012 before selling the Brazilian operations to SantaCruz in 2016.
FAQs
Who founded Celesio AG?
Franz Ludwig Gehe founded the company as Gehe & Comp. in Dresden, Germany on May 1, 1835. The merchant established the business to wholesale drugs, chemicals, and pharmaceutical products to local apothecaries.
When did Celesio AG change its name from GEHE AG?
GEHE AG changed its name to Celesio AG on April 24, 2003. Shareholders approved the name change with 99.98% majority during the annual general meeting, marking the company’s 100th year as a public limited company.
Who acquired Celesio AG?
McKesson Corporation acquired Celesio AG in January 2014 for approximately €6.1 billion. The American healthcare company paid €23 per share to gain majority control of the European pharmaceutical distributor.
What happened to Celesio AG after the McKesson acquisition?
Celesio AG continued operating as a McKesson subsidiary until September 2017, when it was renamed McKesson Europe AG. The company was later sold to Phoenix Group in October 2022 for $892 million.
What businesses did Celesio AG operate?
Celesio AG operated pharmaceutical wholesale distribution, retail pharmacy chains including LloydsPharmacy, and manufacturer services. The company supplied over 65,000 pharmacies and hospitals across 16 European countries through 133 wholesale branches.